Atropine Consumption Market Synopsis:
In this report, LP Information covers the present scenario with the base year being 2017 and the growth prospects of global Atropine market for 20182023.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
Atropine industry is relatively fragmented, manufacturers are mostly in the North America, Europe and Asia, and China market production volume accounted for more than 25.43% of the total production volume of global Atropine in 2017. C²PHARMA is the world leading manufacturer in global Atropine market with the market share of 9.19%, in terms of revenue, followed by RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng Group and CR DoubleCrane.
Compared to 2016, Atropine market decreased revenue by 5.69 percent to $549.60 million worldwide in 2017 from $582.76 million in 2016. As for the volume segment, global Atropine production decreased to 3862.8 Kg from 4247.4 Kg in 2013. Due to low prices, small profit margins and a relatively narrow market, many companies have abandoned production of atropine, and a shortage of atropine has appeared in the market. This is the result of longterm effects of market behavior.
The average price of Atropine will fall further. The product average price declined in the past few years due to its cheap drug properties, and the average price will keep this trend in the few future years due to market vicious circle.
Over the next five years, LPILP Information projects that Atropine will register a 1.6% CAGR in terms of revenue, reach US$ 500 million by 2023, from US$ 550 million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Atropine market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Injection
Drop
Gel
Segmentation by application:
Gastrointestinal
Ophthalmology
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng Group
CR DoubleCrane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Atropine consumption value & volume by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Atropine market by identifying its various subsegments.
Focuses on the key global Atropine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Atropine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market growth potential, opportunities, drivers, industryspecific challenges and risks.
To project the consumption of Atropine submarkets, with respect to key regions along with their respective key countries.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
